CTOs on the Move

HealthPlan Services

www.healthplan.com

 
HealthPlan Services (HPS) is the nation’s largest independent provider of sales, benefits administration, retention, reform and technology solutions to the insurance and managed care industries. Headquartered in Tampa, Florida, HPS was founded in 1970 and employs 1,500+ associates. HPS stands at the forefront of the insurance industry, providing exchange connectivity, administration, distribution and technology services to insurers of individual, small group, voluntary and association plans, as well as valuable solutions to thousands of brokers and agents, nationwide. Our Go-To-Exchange® platform combines the services of ExchangeLink, SalesLink, ServiceLink and LoyaltyLink products to enable the connectivity, enrollment, reconciliation, eligibility, subsidy and ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Care Net

Care Net is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AbboMax

AbboMax is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KaloBios

KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.

Musculoskeletal Transplant Foundation

Musculoskeletal Transplant Foundation, Inc is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phoenixortho

Phoenixortho is a Red Oak, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.